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Abstract
Tendon ruptures and/or large losses remain to be a great 
clinical challenge and often require full replacement of 
the damaged tissue. The use of auto- and allografts or 
engineered scaffolds is an established approach to restore 
severe tendon injuries. However, these grafts are commonly 
related to scarce biocompatibility, site morbidity, chronic 
inflammation and poor biomechanical properties. Recently, 
the decellularisation techniques of allo- or xenografts using 
specific detergents have been studied and have been found 
to generate biocompatible substitutes that resemble the 
native tissue.
 This study aims to identify a novel decellularisation 
protocol for large equine tendons that would produce an 
extracellular matrix scaffold suitable for the regeneration 
of injured tendons in humans. Specifically, equine tendons 
were treated either with tri (n-butyl) phosphate alone, 
or associated to multiple concentrations of peracetic 
acid (1, 3 and 5 %), which has never before been tested 
in vitro. Samples were then analysed by histology and 
with biochemical, biomechanical, and cytotoxicity tests. 
The best decellularisation protocol, resulting from these 
examinations, was selected and the chosen scaffold was 
re-seeded with murine fibroblasts. Resulting grafts were 
tested for cell viability, histologic analysis, DNA and 
collagen content. The results identified 1 % tri (n-butyl) 
phosphate combined with 3 % peracetic acid as the most 
suitable decellularised matrix in terms of biochemical and 
biomechanical properties. Moreover, the non-cytotoxic 
nature of the decellularised matrix allowed for good 
fibroblast reseeding, thus demonstrating a biocompatible 
matrix that will be suitable for tendon tissue engineering 
and hopefully as substitutes in severe tendon damages.
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Introduction
Traumatic acute events leading to tendon losses, as well 
as ruptures related to degenerative tendinopathy, require 
a replacement of the damaged tissue. In particular, 
the incidence of acute events occurring in the flexor 
and extensor tendons of the hand is close to 4.83 and 
18/100.000 cases per year, respectively. Similarly, Achilles 
tendon ruptures occur in 12-18/100.000 per year, and 
rotator cuff tendon lesions in 3.73/100.000 cases per year 
(Shearn et al., 2011; Clayton and Court-Brown, 2008). 
Yet, in these cases, the healing process does not efficiently 
restore the native tendon structure and function, despite 
the surgical intervention, with a high rate of re-tear 
(Sharma and Maffulli, 2006; Andarawis-Puri et al., 2015). 
Nowadays, tendon autografts are the common choice for 
the reconstruction of tendon integrity (Yao et al., 2015), 
despite their limited supply, high donor-site morbidity, 
and poor functional outcomes (Gazdag et al., 1995; Lovati 
et al., 2016). To overcome these limitations, the field of 
tissue engineering widely investigated the generation of 
cell-seeded scaffolds to promote regeneration and implant-
tissue integration (Kuo et al., 2010; Shearn et al., 2011). An 
ideal bioengineered tendon graft should be biocompatible, 
support cell attachment and host integration, and have 
biochemical and mechanical properties similar to the 
native tendon. However, synthetic scaffolds were not able 
to satisfy mechanical and structural properties (Zhang 
and Chang, 2003), and result in poor functional outcomes 
(Garvin et al., 2003). Allografts have also been considered 
a useful source to improve the clinical outcomes in tendon 
replacement (Gazdag et al., 1995). However, they have 
been shown to induce chronic inflammatory and immune 
responses compromising the scaffold biomechanics, and 
require a long time for the integration and remodelling. 
Moreover, they can be a potential source of infectious 
disease transmission (Pinkowski et al., 1996; Zheng et al., 
2005; Eastlund 2006). In recent years, decellularisation 
techniques of allo- or xenografts have been highly 
investigated due to their biocompatibility, extracellular 
matrix and biomechanical features resembling native tissue 
(Lovati et al., 2016; Harrison and Gratzer, 2005; Cartmell 
and Dunn, 2000; Tischer et al., 2007; Gilbert et al., 2006) 
along with the absence of adverse immune response due 
to the removal of donor cells and antigen debris (Hudson 
et al., 2004; Macchiarini et al., 2008; Ueda et al., 2006).
 In our previously published review on tendon 
decellularisation (Lovati et al., 2016), we identified in 
the equine species the most suitable in terms of proper 
dimensions, tissue retrieval and supply, as also supported 
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by others (Youngstrom et al., 2013; Burk et al., 2014). In 
addition, we recognised tri(n-butyl) phosphate (TBP) as 
the most efficient agent to reach a complete cell removal 
while maintaining all requirements for a functional and 
safe tendon substitute, as also described in other animal 
species (Cartmell and Dunn, 2000; Deeken et al., 2011). 
The peracetic acid (PAA) has been commonly reported as 
a potent oxidizing agent used to sterilise collagen tissues 
(Gilbert et al., 2006; Kemp, 1994). Moreover, PAA can be 
also used to enhance tissue permeability for the detergent 
penetration and cell colonisation within the dense tendon 
structure (Deeken et al., 2011; Whitlock et al., 2007; Woon 
et al., 2011; Woon et al., 2012; Raghavan et al., 2012; 
Schmitt et al., 2013). Among these studies, only Woon et 
al. (2011) compared the efficacy of different concentrations 
of PAA (2, 5 and 10 %) after sodium dodecyl sulphate 
(SDS)-based decellularisation of human tendons. Similarly, 
only Deeken et al. (2011) studied the efficacy of 0.1 % 
PAA associated to 1 or 2 % TBP detergent to decellularise 
porcine tendons.
 Our study aims to identify an effective decellularisation 
protocol to obtain an extracellular matrix scaffold capable 
of both supporting viable reseeded cells and integrating 
with the host tissues facilitating the regeneration of injured 
tendons.
 In the present study, we aim to remove intrinsic tendon 
cells from large sized equine superficial digital flexor 
tendons (SDFT) by means of the 1 % TBP detergent 
associated or not to multiple concentrations of PAA (1, 3 
and 5 %), as never tested in vitro. Our hypothesis is that 
the treatment with low concentrations of PAA could aid 
in removing the cellular component of the equine SDFT 
without altering the intrinsic structure of the decellularised 
matrix, such as sulphated glycosaminoglycans (sGAG) that 
are highly conserved across species (Gilbert et al., 2006; 
Getgood and Bollen, 2010) and are fundamental for the 
tissue integration and regeneration. The purpose of this 
study is to identify a valid and standardised protocol of 
tendon decellularisation in order to further develop suitable 
xenografts as promising biological substitutes – different 
from allo- and autografts – in case of severe tendon lesions. 
After a validation by in vivo testing, the novel off-the-shelf 
scaffold could be used to replace tendon damages and to 
promote an efficient host integration and remodelling, thus 
offering an early return to function after implantation.
Materials and Methods
Experimental design
Ten equine SDFTs were decellularised with a novel 
combination of two acting agents at various concentrations. 
Each sample, including the native tendon, was then analysed 
using various techniques: histology and histomorphometry 
(Haematoxylin and Eosin – H&E; Alcian blue staining), 
biochemical characterisation (DNA, GAG and collagen 
content), biomechanical characterisation, and cytotoxicity 
testing. Each investigation was performed on samples 
from each donor in duplicate. The best decellularisation 
protocol was chosen following the aforementioned 
examinations and the resulting tendon decellularised 
scaffold was reseeded with murine fibroblasts and tested 
for cell viability, histologic analysis, and DNA and collagen 
content.
Harvesting and preparation of equine digital flexor 
tendons
Fresh equine SDFT were harvested from the forelimbs 
of adult horses (n = 10; mean age 10 ± 7 years) at the 
slaughterhouse. A 10 cm length portion of the mid-third of 
the SDFT was excised, dissected for exceeding paratenon, 
washed in phosphate-buffered saline (PBS +/+, Sigma 
Aldrich, Milan, Italy), and immediately dry-stored at 
−80 °C. Then, specimens were thawed at room temperature 
(RT) in saline solution and longitudinally sectioned into 
five slices by means of an electric slicer (RGV 25, RGV 
s.r.l., Como, Italy), then frozen again at −80 °C until 
processing. The specimen dimensions were approximately 
10 cm (length) × 1.5 cm (width) × 0.3 cm (thickness).
Decellularisation protocols and methods
Two tendon slices of each donor were chosen randomly 
and treated using one of the following protocols: (1) 1 % 
TBP followed by 1 % PAA; (2) 1 % TBP followed by 3 % 
PAA; (3) 1 % TBP followed by 5 % PAA, and (4) 1 % TBP. 
A slice of each donor was stored at −80 °C to represent the 
untreated control (native tendon, NT). Decellularisation of 
the scaffolds was performed using a multiple step process. 
Each step was carried out in 50 mL tubes in 40 mL of 
different solutions.
 For the thawing phase, slices were immersed in 
PBS without sodium and magnesium (PBS-/-) at RT for 
30 min. Then, all specimens were decellularised in 1 % 
TBP buffered in 1 M Tris-HCl pH 7.8 for 24 h at RT 
under agitation on an orbital stirrer. Following this, slices 
were rinsed twice in ddH2O at RT for 15 min and stored 
in PBS -/- at 4 °C for 24 h to remove residual detergents. 
After this, in order to remove any residual DNA within 
the dense tendon matrix, the specimens were immersed 
in 0.0025 % DNAse-I in PBS +/+ at RT under agitation 
for 4 h, followed by two washes in ddH2O for 15 min and 
two washes in PBS -/- for 15 min. The final step involved 
an incubation in 1 %, 3 % or 5 % aqueous solution of PAA 
(stock solution 32 %) for groups 1, 2 and 3 under agitation 
at RT for 4 h. Specimens of group 4 did not undergo to any 
PAA treatment, but they were incubated in PBS -/- under 
agitation at RT for 4 h as a positive control to evaluate the 
PAA efficacy. Finally, slices were rinsed twice in ddH2O 
for 15 min, twice in PBS -/-, and then either stored in 
PBS -/- at 4 °C for 24 h for the biomechanical analysis or 
dry-stored at −80 °C for other analyses. All reagents were 
Sigma-Aldrich (Milan, Italy).
Histologic evaluation
Samples for histology were fixed in 10 % buffered 
formaldehyde for 24 h at RT, dehydrated, paraffin 
embedded and longitudinally sectioned at 5 µm. Sections 
were stained with H&E to assess the cellular components 
(intact cells, cell debris or vacuolated nuclei) and collagen 
fibre morphology, and Alcian blue staining to evaluate the 
sulphated proteoglycan content, according to standard 
protocols. Photomicrographs were captured using an 
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Olympus IX71 light microscope and an Olympus XC10 
camera (Tokyo, Japan). To semi-quantitatively assess the 
cell density, photomicrographs were evaluated by two 
blinded observers by quantifying the number of stained 
nuclei using Image J 1.45s® software (open source: http://
rsbweb.nih.gov/ij) and data were reported as mean cell 
density (cells/mm2) per treatment and as percentage of 
cell removal.
Biochemical characterisation: DNA, sGAG and 
collagen content
Sample digestion for DNA and sGAG quantification
Segments of decellularised, native tendon, and eventually 
reseeded matrix were weighed in order to normalise the 
biochemical data on sample dry weight. Then, specimens 
were minced and digested in 2 mg/mL proteinase K 
(pH 7.6) (Sigma-Aldrich, Milan, Italy) at 56 °C for 16 h 
under agitation. Digested samples were centrifuged at 
10,000 ×g for 10 min at RT and the supernatant was 
collected for analyses.
 DNA assay was performed to quantify the potential 
cellular remains after the decellularisation processes. 
DNA content was measured in the supernatant using a 
cell proliferation assay (CyQuant® kit – Life Technologies, 
Monza, Italy) following the manufacturer’s instructions. 
Fluorescence was measured by means of a spectrophotometer 
(Perkin Elmer Victor X3 microplate reader) at an excitation/
emission wavelength of 480/520 nm. The quantification 
of sGAG was performed on decellularised and native 
tendons using the 1,9-dimethylmethylene blue (DMMB) 
dye-binding assay (Sigma-Aldrich, Milan, Italy) and 
compared to a standard curve of chondroitin sulphate 
(Blyscan – Biocolor, Magenta, Italy). Briefly, the samples 
were incubated in 40 mM glycine/NaCl (pH 3.0) with 
16 mg/mL DMMB at RT. The sGAG concentration was 
determined by reading the absorbance at 500 nm (Perkin 
Elmer Victor X3 microplate reader).
 Data from DNA and sGAG content analysis were 
normalised to the sample dry weights.
Sample digestion for collagen quantification
In order to remove the proteoglycans, about 10 mg of each 
sample – decellularised and native tendons, and reseeded 
matrices – were stirred in a solution of 4 M guanidine-
HCl in 0.05 M sodium acetate (pH 5.8) at 4 °C, and then 
centrifuged at 30000 ×g for 30 min at 4 °C. The supernatant 
was removed and samples washed three times using 0.5 M 
acetic acid. The collagen residue was added to a solution 
of 1 mg/mL pepsin in 0.5 M acetic acid at 4 °C for 3 d, 
then samples were centrifuged at 30000 ×g for 30 min 
at 4 °C and the supernatant was collected as described 
elsewhere (Taskiran et al., 1999). Following, 100 µL of 
samples were mixed with 900 µL of Sirius Red in acetic 
acid (0.5 M, all reagents from Sigma-Aldrich, Milan, Italy) 
and incubated at RT for 20 min. After the incubation period, 
the samples were centrifuged at 16,000 ×g for 30 min, the 
supernatant was disposed, and the collagen bound dye 
complex was dissolved in 0.5 M sodium hydroxide (Alkali 
reagent – Biocolor, Magenta, Italy). The absorbance of the 
supernatant was read in a spectrophotometer at 540 nm 
against sodium hydroxide (0.5 M) as blank. The obtained 
optical densities were interpolated in a curve of absorbance, 
using collagen type I from rat-tail soluble in acetic acid 
(BD Bioscience, Milan, Italy) as standard.
 Data obtained were normalised to the sample dry 
weight and expressed as total acid-soluble collagen (µg/
mg).
Biomechanics
To perform the biomechanical tests, rectangular specimens 
were obtained from the decellularised and native tendons. 
To avoid the sample slip at the machine grips, the final 
portions of the rectangular specimens were interposed 
and fixed by cyanoacrylate glue between two sheets of 
sandpaper.
 Mechanical testing was performed at RT using 
an electromagnetic testing machine (MTS Synergie, 
MTS Systems Corporation, Eden Prairie, MN, USA), 
equipped with a load cell of 1 kN. The mean dimensions 
of the samples from equine decellularised or native 
tendons, measured between the grips, were 39 ± 8 mm, 
14 ± 2 mm width and 2.4 ± 0.6 mm thickness. Tension 
protocol consisted of multi-ramp stress relaxation tests, 
followed by the strain-controlled tension up to failure. 
For stepwise stress relaxation tests, three tension steps up 
to 2 % strain were applied, at 1 %/s strain rate, followed 
by 1,000 s stress relaxation. The machine crosshead was 
returned to the initial position before running the failure 
test, also conducted at 1 %/s strain rate. The pure elastic 
response was calculated from the equilibrium data of the 
stress relaxation tests, and indicated as Er. The tendon 
hyperelastic response and the failure stress and failure 
strain were derived from the failure test, along with the 
elastic response at high strains, elastic modulus (EM), 
evaluated as the slope of the final linear portion of the 
stress-strain curve. Five preconditioning cycles were 
applied to every sample before the tests.
In vitro cytotoxicity of the decellularisation 
detergents and cytocompatibility of the decellularised 
tendon matrix
These analyses were carried out to assess the potential 
cytotoxicity of the decellularisation detergents of the tested 
experimental solutions on NIH-3T3 murine fibroblasts.
 Firstly, NIH-3T3 cells were seeded 3 × 103/cm2 in 
96-well plates in complete medium (CM) consisting of 
Dulbecco’s modified Eagle’s medium high glucose (Gibco, 
Life Technologies, Monza, Italy), 10 % foetal bovine 
serum (FBS, Hyclone, Life Technologies, Monza, Italy), 
100 U/mL penicillin-streptomycin, 2 mM L-glutamine, 
1 % sodium pyruvate and 1 % HEPES (all from Gibco, 
Life Technologies, Monza, Italy). Samples derived from 
decellularised tendons (treatments) and native tendons 
(NT) were cut into 5 × 5 mm pieces and placed into 70 % 
ethanol for 10 min under agitation. Then, they were washed 
three times in PBS and incubated in 5 mL of CM for 96 h at 
37 °C under agitation, hereon called conditioned media and 
used to establish an indirect toxicity test. Indeed, the NIH-
61 www.ecmjournal.org
M Bottagisio et al.                                                                                      Decellularised matrices as tendon substitutes
3T3 cells were cultured in 200 µL of the aforementioned 
conditioned media, fresh CM (negative control, NC) or 
0.5 % Triton-X100 medium (positive control, PC) for 72 h.
 Thus, the cell viability was analysed by a colorimetric 
assay in which the 3(4,5-dimethylthiazole-2-yl)-2,5-
diphenyltetrazolium-bromide (MTT, Sigma-Aldrich, 
Milan, Italy) to formazan blue by viable cells. Briefly, 
500 μL of MTT in DMEM without phenol red (0.5 mg 
MTT/mL, dilution 1:10) was added to each well containing 
the cell monolayer and incubated at 37 °C for 4 h. Following 
this, medium was removed and the formazan crystals were 
solubilised with 500 μL of pure isopropanol for 30 min 
at RT under agitation. The absorbance was determined at 
570 nm by means of a microplate reader (Perkin Elmer 
Victor X3). Three replicates were considered per sample. 
Data were reported as absorbance values. Moreover, 
the mitochondrial function was then calculated for the 
cytotoxicity assay, as a percentage of the NC considered 
as 100 %.
Repopulation of the decellularised matrix
Tendons decellularised by means of TBP + 3 % PAA were 
cut into pieces measuring 5 mm (length) × 5 mm (width) 
× 3 mm (thickness). Then, they were sterilised into 70 % 
ethanol for 10 min under agitation and washed three 
times in PBS, finally, left unseeded as negative control 
(decellularised matrix, DM) or seeded with NIH-3T3 
murine fibroblasts at a concentration of 2.6 × 104/mm3 
(reseeded matrix, RM) and cultured in CM. To seed the 
grafts, 150 µL of the cell suspension was placed onto the 
surface of the tendon. After 2 h of incubation at 37 °C in a 
5 % CO2 in humidified incubator, the medium was added 
and both the unseeded and seeded tendon matrices were 
statically cultured for 7 d. The CM was changed every 3 d. 
Samples were then evaluated for the seeding efficiency by 
measuring the DNA content of the initial cell amount and 
of the retrieved cells onto the reseeded matrix after 24 h. 
Furthermore, after 7 d, the samples were analysed for 
histology (H&E), Live & Dead assay, and collagen content.
Live & Dead assay
To evaluate the cell viability of NIH-3T3 fibroblasts seeded 
onto the decellularised matrix, a Live & Dead Viability/
Cytotoxicity test (Life Technologies, Monza, Italy) was 
performed according to the manufacturer’s instructions. 
Briefly, after 7 d of culture, the DM and RM constructs 
were labelled with Live & Dead stain consisting in 2.5 µL 
calcein AM and 10 µL ethidium homodimer-1 dissolved 
in 5 mL of PBS. Then, the samples were incubated at RT 
for 30 min before analysing microscopically. Live cells 
appeared green, while dead cells fluoresced red.
Statistical analysis
Data were recorded from ten SDFT derived from ten 
different horses (n = 10). Each investigation was performed 
on samples from each donor in duplicate. The cytotoxicity 
test was performed in triplicate.
 The normal distribution of data was ascertained with 
the Shapiro-Wilk test. Comparisons among groups were 
analysed with one-way analysis of variance (ANOVA) 
(Graph Pad Prism v5.00 Software Inc., San Diego, 
CA, USA) coupled with Bonferroni’s post hoc test. For 
reseeding studies, a paired t-test was performed. All data 
are expressed as means ± standard error (SE), unless 
specified otherwise. Values of p < 0.05 were considered 
statistically significant.
Results
Histologic analysis
The H&E photomicrograph of native tendons showed 
normal elongated and intact cell nuclei of tendon fibroblasts 
laying between regular collagen fibres in lacunae (Fig. 1a). 
The sulphated proteoglycans, located within the endotenon 
and near the blood vessels, were stained deep blue with the 
Alcian Blue. The well-organised collagen fibres appeared 
like pink coloured compact bundles (Fig. 1b). Native 
tendons depicted a common collagen pattern with a cell 
density of 206 ± 142 cells/mm2 with a very significant 
difference (p < 0.001) compared to all the decellularised 
tendons (Fig. 1c).
 Tendons treated with both TBP + 1 % PAA and 
TBP + 3 % PAA had a decreased cell density compared to 
the NT with a 69 % and 98 % of cells removed, respectively, 
and histologic analysis showed a well-preserved pattern of 
the collagen fibres demonstrating the maintenance of the 
tissue architecture. In TBP + 1 % PAA, the H&E staining 
depicted a mild presence of intact cells with well-formed 
nuclei, together with a large number of vacuolated cell 
nuclei or diffuse cellular debris (Fig. 2a). TBP + 3 % 
PAA showed very few vacuolated cells associated with 
scarce cell debris (Fig. 2c). For the Alcian blue staining, 
the tendons treated with TBP + 1 % PAA showed well-
preserved proteoglycan content (Fig. 2b). Conversely, 
TBP + 3 % PAA treated samples depicted a mild decrease 
of proteoglycans, despite no alteration of collagen fibres 
was detected in both TBP + 1 % PAA and TBP + 3 % PAA 
(Fig. 2d).
 Specimens treated with TBP + 5 % PAA had 99 % cell 
removal with respect to the NT. In this group, no nuclear 
material (vacuolated nuclei or cell debris) was evident at 
the H&E staining. Here, a sparsely distributed opening of 
the collagen fibres was identified together with an increased 
pattern of the tendon crimp (Fig. 3a). The Alcian Blue 
staining in TBP + 5 % PAA treated tendons demonstrated 
a significant decrease of proteoglycans that appear as light 
blue bundles within the augmented inter-fascicular spaces. 
Similarly, also the collagen fibres appeared as light pink 
coloured bundles among the disrupted tendon crimp pattern 
(Fig. 3b).
 Despite a significantly lower cell density in the TBP 
treated samples compared to NT with 63 % cell removal, 
the remaining cells seemed to be intact with no signs of 
vacuolisation of the nuclei or cell disruption. Similarly 
to TBP + 1 % PAA and TBP + 3 % PAA, TBP treatment 
preserved a good pattern of the collagen fibres (Fig. 3c). 
Overall, TBP treated samples showed a well-preserved 
proteoglycan content similar to those treated with 
TBP + 1 % PAA, as well as well-organised collagen fibres 
appearing like pink coloured compact bundles (Fig. 3d).
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Biochemical analyses on decellularised and native 
tendons
The ability of the decellularisation protocols to remove the 
cell component was quantified by DNA content analysis. 
The DNA content in all treated samples was reduced 
significantly compared to the NT (p < 0.001), supporting 
the histologic cell count. More importantly, a decreased 
DNA content was found in samples treated with TBP + 3 % 
PAA and TBP + 5 % PAA compared to those treated 
with TBP + 1 % PAA and TBP (p < 0.01 and p < 0.001, 
respectively). The DNA content in samples treated with 
TBP + 3 % PAA and TBP + 5 % PAA responds to the 
minimal criteria (50 ng/mg dry weight) set by Crapo et 
al. (2011) to satisfy the intent of tissue decellularisation 
(Fig. 4a, dotted line). Fig. 4b, reporting the quantification 
of the sGAG content, depicted a significant decrease of 
sGAG content in tendon treated with TBP + 5 % PAA 
when compared to NT (p < 0.001), and also compared 
to TBP + 1 % PAA and TBP (p < 0.001 and p < 0.01, 
respectively). No significant differences were detected 
in the samples decellularised with TBP + 1 % PAA, 
TBP + 3 % PAA and TBP with respect to NT.
Total collagen content in decellularised and native 
tendons
A significant decrease in collagen content was found in 
tendons treated with all decellularisation protocols with 
respect to NT (p < 0.001) (Fig. 4c). In contrast, the TBP 
group showed a higher collagen content compared to 
TBP + 1 % PAA (p < 0.05), TBP + 3 % PAA and TBP + 5 % 
PAA (p < 0.01).
Biomechanical tests for decellularised and native 
tendons
The results of stress-relaxation tests conducted on 
native and decellularised samples with TBP + 1 % PAA, 
TBP + 3 % PAA, TBP + 5 % PAA and TBP are reported 
in Fig. 4. The Fig. 5a reports a representative example 
of a multi-step relaxation test and the results of the 
relaxation moduli (Er) for the three ramps are depicted in 
the histogram in Fig. 5b. The results of the failure tests 
report a hyperelastic response, as shown in Fig. 5c for a 
representative specimen. The Fig. 5d shows the elastic 
modulus (EM) at high strains. The tendons treated with 
all the decellularisation protocols did not show significant 
Fig. 1. Representative histologic panel of native tendons (NT) (scale bars 100 µm). Native tendons stained with 
haematoxylin and eosin (H&E) (a) and with Alcian blue (b). Black arrow = proteoglycans; asterisk = collagen fibres 
in compact bundles. The histogram reports the histomorphometric cell count (cells/mm2) of the native and treated 
tendons. Comparisons among groups were analysed with one-way analysis of variance (ANOVA) coupled with 
Bonferroni’s post hoc test. * p < 0.05; ** p < 0.01; a, *** p < 0.001.
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Fig. 2. Representative histologic panel of tendons decellularised with TBP + 1 % PAA and TBP + 3 % PAA (scale bars 
100 µm). The left panels depict haematoxylin and eosin (H&E) staining; the right panels depict Alcian blue staining. 
Tendon decellularised with TBP + 1 % PAA (a,b); tendon decellularised with TBP + 3 % PAA (c,d). Black arrow = 
proteoglycans; asterisk = collagen fibres in compact bundles.
Fig. 3. Representative histologic panel of tendons decellularised with TBP + 5 % PAA and TBP alone (scale bars: 100 µm). 
The left panels depict haematoxylin and eosin (H&E) staining; the right panels depict Alcian blue staining. Tendon 
decellularised with TBP + 5 % PAA (a,b); tendon decellularised with TBP alone (c,d). Black arrow = proteoglycans; 
asterisk = collagen fibres in compact bundles.
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changes in EM compared to the NT, only a significant 
difference was found between TBP + 1 % PAA and 
TBP + 5 % PAA (p < 0.05) as reported in Fig. 5d. This 
finding indicated a stiffer behaviour of tendons treated with 
TBP + 1 % PAA. The EM value for NT was 181 ± 78 MPa.
 Failure stains and stress are shown in Fig. 5. There 
was not a significant difference either in the percentage of 
the failure strain measured after the decellularisation with 
respect to the NT (Fig. 5e) or in the failure stress among 
groups (Fig. 5f).
Cytotoxicity tests of the decellularised tendons
NIH-3T3 murine fibroblasts were used to evaluate the 
cytotoxicity of decellularised tendon matrices using an 
MTT assay (Fig. 6). Absorbance values of cells cultured in 
conditioned media as well as NC were significantly higher 
than PC for p < 0.001, indicating a normal cell proliferation. 
Cells cultured in TBP conditioned medium showed a lower 
absorbance compared to the NC (p < 0.001). Similarly, 
cells cultured in the TBP + 5 % PAA conditioned medium 
had a significantly lower absorbance rate compared to 
the NC (p < 0.001), but also with respect to cells cultured 
in TBP + 1 % PAA and TBP + 3 % PAA conditioned 
media (p < 0.01), and the NT conditioned medium 
(p < 0.05), indicating a decrease in cell proliferation. The 
mitochondrial function was defined as the relative cell 
number on the NC which showed a 89, 91, 74 and 81 % of 
cell viability when cells were cultured in TBP + 1 % PAA, 
TBP + 3 % PAA, TBP + 5 % PAA and TBP conditioned 
media, respectively.
Cell colonisation of the decellularised matrix
Equine tendons treated with TBP + 3 % PAA, which was 
identified as the optimal protocol, were reseeded with NIH-
3T3 fibroblasts for 7 d. After culture, the Live & Dead assay 
demonstrated a preserved viability of the seeded cells (Fig. 
7a,b), specifically, 80 ± 9 % of living cells and 20 ± 9 % 
of dead cells. Moreover, cells were well distributed on 
Fig. 4. DNA, sulphate glycosaminoglycans (sGAG) and collagen content. Effects of the decellularisation protocols on 
DNA (ng/mg dry weight) (a); the dotted line represents the limit of DNA content at 50 ng/mg dry weight identified 
by Crapo et al. (2011). Effects of the decellularisation protocols on sGAG content (µg/mg dry weight) (b). Effects of 
the decellularisation protocols on collagen content (µg/mg dry weight) (c). Comparisons among groups were analysed 
with one-way analysis of variance (ANOVA) coupled with Bonferroni’s post hoc test. * p < 0.05; ** p < 0.01; a, 
*** p < 0.001.
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Fig. 5. Biomechanical analysis: relaxation moduli, elastic modulus, failure strain and failure stress. Representative 
example of a multi-step relaxation test (a). Histogram of the relaxation moduli (Er) for the three ramps comparing the 
native tendon (NT) and the decellularisation protocols (b). Representative graph of a failure test (c). Elastic modulus 
(MPa) comparison between NT and the decellularisation protocols (d). Failure strains (%) comparing the NT and 
the decellularisation protocols (e). Failure stress (MPa) comparing the NT and the decellularisation protocols (f). 
Comparisons among groups were analysed with one-way analysis of variance (ANOVA) coupled with Bonferroni’s 
post hoc test. * p < 0.05.
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the surface of the construct forming a compact cell layer 
onto the RM. Similarly, the H&E histologic staining 
depicted a dense and fibrous sheet of NIH-3T3 fibroblasts 
on the surface of the RM (Fig. 7c,d). These data strictly 
correlated with the higher DNA content measured in the 
RM constructs compared to the DM (p < 0.001) (Fig. 7e). 
Moreover, the collagen content in RM increased 1.85-fold 
with respect to the DM for values of 7.41 ± 1.17 µg COLL/
mg dry weight, demonstrating both cell viability and an 
enhanced metabolic activity.
Discussion
The use of xenogeneic decellularised tendon matrix 
has become an attractive approach to replace damaged 
tendons while preserving biomechanical properties, 
biocompatibility and tendon architecture (Lovati et al., 
2016). Several decellularisation protocols have been 
investigated to generate acellular tendon scaffolds 
(Cartmell and Dunn, 2000; Cartmell and Dunn, 2004; 
Youngstrom et al., 2013; Youngstrom et al., 2015; Burk 
et al., 2014; Whitlock et al., 2007; Woon et al., 2011; 
Pridgen et al., 2011; Xing et al., 2014), with the aim to 
preserve as much as possible a tendon ECM suitable for 
cell colonisation.
 Despite the interesting properties of equine flexor 
tendons in terms of material retrieval, mechanical strength 
and limited zoonotic diseases (Lovati et al., 2016), only 
a few studies performed the tendon decellularisation in 
this species (Youngstrom et al., 2013; Youngstrom et al., 
2015; Burk et al., 2014; Durgam et al., 2012), although 
an optimum gold standard method has not been reported 
in the literature yet.
 The aim of our study is to decellularise tendons to 
be used as suitable substitute for injured tendons, by 
resembling the native mechanical properties and improving 
the integration with the host tissues. Thus, with the aim 
to identify a standard decellularisation protocol for 
large equine tendons, the present study investigates the 
combination of two primary reagents – TBP and PAA. 
Their ability to efficiently remove resident cells and to 
increase the matrix porosity for following cell colonisation, 
while preserving the main features of functional tendons, 
is tested. Particularly, we employed a zwitterionic 
detergent, the TBP, known to be also a virucidal and 
bacteriostatic agent, frequently used in scaffold preparation 
for implantable grafts (Crapo et al., 2011; Deeken et al., 
2011). Furthermore, to decellularise dense tissues such 
as tendon, TBP has been shown to be more effective 
than other detergents like Triton-X100 and SDS, with a 
good retention of the ECM constituents and mechanical 
properties resembling the native tissue (Cartmell and Dunn, 
2000; Deeken et al., 2011).
 Here, we analysed the efficacy of 1 % TBP associated 
or not with different concentration of PAA (1, 3, and 5 %) 
to decellularise the equine SDFT. To do this, we worked 
on long length grafts from equine native tendon 3 mm 
thick slices, as the most suitable measure to obtain reliable 
mechanical properties of normal tendon bundles (Qin et 
al., 2012; Ning et al., 2012).
 Our results indicated that TBP and TBP + 1 % PAA 
protocols did not allow the efficient removal of DNA, 
despite the histologic findings suggesting that these 
treatments could maintain a good pattern of collagen 
fibres, as also demonstrated by others (Cartmell and Dunn, 
2000; Cartmell and Dunn, 2004). Other groups, who used 
1 % TBP to decellularise tendons both from equine and 
human species (Youngstrom et al., 2013; Pridgen et al., 
2011), described similar DNA values. More importantly, 
TBP + 3 % PAA and TBP + 5 % PAA treatments 
significantly reduced the resident cell quantity by obtaining 
DNA values lower than 50 ng/mg dry weight, representing 
the minimal criteria for potential clinical use set by Crapo et 
al. (2011). This low DNA content was supported also by our 
histomorphometric data, potentially avoiding any adverse 
immune response after transplantation (Crapo et al., 2011). 
The percentage of cell removal obtained by TBP + 3 % 
PAA (98 %) and TBP + 5 % PAA (99 %) treatments 
are the most effective data published to date in the field 
Fig. 6. MTT assay results for potential 
cytotoxicity of the decellularisation protocols. 
Comparisons among groups were analysed with 
one-way analysis of variance (ANOVA) coupled 
with Bonferroni’s post hoc test. * p < 0.05; 
** p < 0.01; a, *** p < 0.001.
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Fig. 7. Reseeded tendon matrix: cell viability, histology and DNA content. Representative panels of the Live & Dead 
of the reseeded and decellularised matrix (scale bars: 200 µm) (a,b). Representative panels of the haematoxylin and 
eosin (H&E) staining of the reseeded and decellularised matrix (scale bars: 500 µm; small boxes scale bar: 200 µm) 
(c,d). Effects of NIH-3T3 cell reseeding on the DNA content (ng/mg dry weight) of reseeded matrix (RM) and 
decellularised matrix (DM). Comparison between groups was analysed with t-test. *** p < 0.001 (e).
of tendon decellularisation (Cartmell and Dunn, 2000; 
Cartmell and Dunn, 2004; Youngstrom et al., 2013). Burk 
et al. (2014) obtained similar DNA data by decellularising 
the equine tendon with more aggressive detergents, such 
as the SDS and Triton-X100 (Woods and Gratzer, 2005). 
Histologically, the increasing concentration of PAA (5 %) 
disrupted the tissue architecture with a sparsely distributed 
opening of the collagen fibres, as also supported elsewhere 
(Deeken et al., 2011; Woon et al., 2011). Conversely, H&E 
showed an optimal pattern in tendons decellularised with 
TBP + 3 % PAA simultaneously with a well-preserved 
sGAG content. Preserving sGAG content is crucial for 
both the collagen fibre organisation (Batson et al., 2003) 
and their water uptake, thus influencing the biomechanical 
features of the matrix (Badylak, 2002). No other studies 
combined TBP to PAA to compare our data. However, 
Youngstrom et al. (2013) found similar values for sGAG 
content in equine tendons treated with 1 % TBP. Other 
DECELLULARISED MATRIXRESEEDED MATRIX
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studies that decellularised human flexor tendons with 
1 % TBP reported sGAG values two times lower than 
those obtained in our experiments (Woon et al., 2011; 
Pridgen et al., 2011). Thus, the optimal cell removal of 
TBP + 3 % PAA without affecting the sGAG content made 
our decellularisation protocol suitable for the generation 
of a functional acellular tendon matrix. After the removal 
of the proteoglycans, the total collagen content was lower 
in all tested decellularisation protocols, particularly in the 
presence of PAA. (Youngstrom et al., 2013; Youngstrom 
et al., 2015) and Pridgen et al. (2011) reported similar 
collagen content results in equine SDFT decellularised with 
1 % TBP, despite the reported increase in collagen content 
of the decellularised tendons compared to the native tissue. 
This remains unclear considering the well-preserved 
biochemical composition declared in these studies. In our 
study, the decreased collagen content of the decellularised 
samples could be related to the quantification of the total 
acid-soluble collagen, thus representing a limitation. For 
this reason, the exact effects of the decellularisation on 
the total collagen denaturation (soluble and insoluble) 
and mechanical integrity of tendons need to be defined in 
future studies. However, the decreased collagen content in 
our samples did not correlate with the histologic collagen 
disorganisation, except for the TBP + 5 % PAA, in which 
a sparsely distributed opening of the collagen fibres was 
identified. Furthermore, despite the collagen content 
reduction, all tested decellularisation protocols produced 
acellular scaffolds with mechanical properties similar to 
the NT for EM, failure stress and strains. Tendons treated 
with TBP + 1 % PAA showed a higher EM compared 
to TBP + 5 % PAA, thus demonstrating their greater 
stiffness. Our data strictly correlated with those obtained 
by (Whitlock et al., 2007) who decellularised chicken 
flexor tendon with the combination of Triton-X100 and 
1.5 % PAA, as well as with data obtained by (Youngstrom 
et al., 2015) on equine SDFT. The biomechanical results 
obtained by (Youngstrom et al., 2013; Youngtstrom et 
al., 2015) on equine tendons are comparable, although 
lower than the data presented in the current study. This 
can be explained by the viscoelastic nature of the tendon 
tissue related to the strain rate used in the tension tests. 
Indeed, we applied a strain rate twice the value used by 
(Youngstrom et al., 2013). The high concentrations of 
PAA (3 % and 5 %) affected the pure elastic response 
of the tendon, as evaluated by the stress-relaxation tests. 
Conversely, the whole viscoelastic behaviour – derived 
from the stress-strain tests – resulted in a greater EM for 
TBP + 1 % PAA, whereas higher concentrations of PAA 
(3 % and 5 %) restored the viscoelastic response resembling 
the NT behaviour. This phenomenon might be due to a 
substantial alteration of the ECM structure related to the 
permeation induced by 3 % and 5 % PAA. In this study, 
the use of tendons derived from different horses in terms 
of age, sex and breeding demonstrated that differences 
between individual horses did not affect the biomechanical 
properties, as also demonstrated by others (Thorpe et al., 
2010). Finally, the results of cytotoxicity showed that 
tendons treated with TBP + 1 % PAA and TBP + 3 % 
PAA have an excellent cytocompatibility. In contrast, 
the increased percentage of peracetic acid in TBP + 5 % 
PAA negatively influenced the viability of NIH-3T3 cells, 
probably due to the presence of greater PAA residuals.
 These promising results encouraged the authors 
to perform a pilot study aimed at evaluating the 
biocompatibility of the decellularised tendon matrix when 
statically reseeded with NIH-3T3 fibroblasts. Our results 
demonstrated good cytocompatibility of the decellularised 
matrix with TBP + 3 % PAA, as depicted by the seeding 
efficiency, Live & Dead assay and histology in RM 
samples, consistent with another study that used NIH-3T3 
cells to repopulate decellularised tendons (Ning et al., 
2012). Moreover, the DNA content of our RM samples 
resembled that described by Woon et al. (2011), in which 
tendons were treated with 5 % PAA. An interesting fold 
increase of the collagen content was measured in the RM 
compared to the DM, reaching values of 7.41 µg/mg dry 
weight, despite these values not resembling those measured 
in the NT. Overall, the data demonstrated the enhanced 
metabolic activity of the fibroblasts reseeded onto the 
tendon matrix.
 In the present study, the decellularisation effectiveness 
was mainly favourable in tendons treated with TBP + 3 % 
PAA with respect to the other protocols in terms of 
cell removal, sGAG preservation, and biomechanical 
properties. According to our findings, TBP was efficient 
–conversely to that reported before in another study (Xing 
et al., 2014) – especially when associated with other agents 
such as PAA. Using 3 % PAA, instead of commonly used 
5 % PAA, facilitated better cell removal together with 
ameliorating the scaffold porosity while maintaining a 
matrix structure and composition similar to the NT. The 
successful combination of TBP + 3 % PAA was also 
supported in our study, evidenced by good cell reseeding 
and by the absence of any adverse cytotoxicity.
 In accordance with our results, the TBP + 3 % PAA 
protocol appears to be most suitable for the decellularisation 
of large tendon grafts, being highly effective in cell removal 
while maintaining both the native matrix structure and the 
cytocompatibility of the obtained scaffold.
 Our protocol – based on a novel and never before 
tested combination of decellularisation agents – led to the 
generation of biocompatible, acellular tendon scaffolds that 
will be suitable for tendon tissue engineering and hopefully 
as substitutes in severe tendon damages, like tears and loss 
of tissue. The next step, before translating this research into 
clinical practice, could be an optimisation of the host cell 
reseeding before implantation in preclinical animal models 
with the goal of replacing tendon defects and regaining a 
complete activity in patients.
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Discussion with Reviewers
Stephen Francis Badylak: Can the authors please explain 
more as to why they chose to use TBP as the principal 
detergent for decellularisation?
Authors: Detergents employed to decellularise tissues are 
typically classified into ionic, non-ionic, and zwitterionic, 
as widely described in our previously published review 
(Lovati et al., 2016). The efficacy of non-ionic (Triton 
X-100), ionic (SDS) and zwitterionic (TBP) detergents to 
obtain a complete tendon decellularisation was compared 
in detail. TBP and SDS are considered the most efficacious 
reagents to obtain an adequate decellularised tendon 
matrix, while preserving the mechanical properties of 
the native tendon. Specifically, TBP has been established 
to be more effective to decellularise dense tissues such 
as tendon than other detergents (Triton X-100 and SDS) 
with varying effects on retention of extracellular matrix 
component, histologic pattern and native mechanical 
properties (Cartmell and Dunn, 2000; Deeken et al., 2011; 
Crapo et al., 2011). Furthermore, thanks to disinfectant 
and bacteriostatic properties, TBP has been successfully 
applied in scaffold preparation for skin grafts, heart valves, 
blood vessels, tendons, ligaments and cartilage (Crapo 
et al., 2011; Deeken et al., 2011). Otherwise, despite an 
excellent decellularisation of tissues, it has also been 
demonstrated that the use of Triton X-100 and SDS, 
associated or not, clearly damaged the glycosaminoglycan, 
increased the collagen tensile strength (Woods et al., 
2005), exhibited numerous cell debris and mild collagen 
damages (Cartmell and Dunn, 2000; Cartmell and Dunn, 
2004). Again, the ionic detergents (SDS) destroy the 
cell membrane, denature proteins, thus affecting the 
collagen structure and are associated with cytotoxicity 
of detergent residuals. Finally, the non-ionic detergents 
(Triton X-100) affect the lipid-lipid and lipid-protein 
interaction, and severely remove glycosaminoglycans from 
the extracellular matrix. According to this, the zwitterionic 
TBP is recommended to decellularise tendons thanks to its 
capability to completely eliminate the cell nuclei, while 
maintaining the extracellular matrix structure. Moreover, 
the capability of TBP to inactivate viruses is crucial in 
reducing the risk for disease transmission in xenogeneic 
tissue transplantation.
Stephen Francis Badylak: Why are equine tendons 
preferred vs. tendons from other mammals? The authors 
cite supply – but arguably porcine tendons would provide 
a better supply.
Authors: Xenografts derive from different animal 
species (bovine, porcine and equine) and, after extensive 
processing techniques; they provide biocompatible 
products for reconstructive surgery of several organs and 
tissues. As mentioned in the manuscript, some advantages 
in using large animals as a source of tissues are their easy 
supply at the slaughterhouse, and the large amount of 
retrievable materials. In particular, tendons have proper 
dimensions and biomechanical characteristics similar to 
humans. Despite the apparent advantages in using porcine 
or bovine as donor species, these retain a great variety of 
transmittable pathogens to humans (Borie et al., 1998). In 
particular, the bovine spongiform encephalopathy (BSE) 
and porcine endogenous retroviruses (PERVs) represent 
the most dangerous transmissible diseases. Specifically, 
infections that cause BSE in the bovine species, when 
transplanted into humans, they can cause the Creutzfeldt-
Jakob disease (CJD) and its variant (vCJD). Otherwise, pigs 
are the main source of tissues and organs already used in 
clinics. However, pigs retain many active or latent viruses 
embedded in their cell genome such as PERV causing 
an AIDS-like disease in the immunosuppressed human 
transplant recipient. In recent years, another infection that 
humans can acquire from pigs is the lethal Ebola virus 
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(EBOV) (Singh et al., 2013). In this scenario, the use of 
equine xenografts has become popular. Indeed, equine 
xenografts are becoming even more used for reconstructive 
surgery (Lovati et al., 2016; Chen et al., 2009; Longo et 
al., 2010), also due to a significantly inferior presence and 
often geographically limited zoonotic diseases (Weese 
2002). However, research on risk on disease transmission 
through equine is still under investigation.
Stephen Francis Badylak: Why does the elastic modulus 
increase with TBP+1 % PAA group? What is the hypothesis 
for this result?
Authors: The exact effect of the TBP, PAA and their 
combinations used in our decellularisation protocols and 
found in the literature is still not fully understood (Crapo 
et al., 2011). Our hypothesis for these results in mechanical 
testing is that a low concentration of PAA, such as 1 %, 
could have altered the ECM structure by determining 
some reticulations in the protein structure and affecting 
the interaction among its components, thus inducing the 
increase of the elastic modulus, as also sustained by others 
(Woon et al., 2011). Similar biomechanical results have 
been also reported by other studies on the decellularisation 
of intestine submucosa (Syed et al., 2014). Differently, 
the greater permeability of the ECM structure as well as 
a probable increased fibre interspaces induced by higher 
concentrations of PAA, such as 3 % and 5 %, could be 
responsible for the restoration of the elastic modulus to 
levels comparable with the native one. In fact, other groups 
observed increased fibre interspaces in human patellar 
tendon allografts treated with PAA (Lomas et al., (2004).
Stephen Francis Badylak: The investigators utilised 3T3 
fibroblasts as an indicator of cellular compatibility. 3T3 
fibroblasts are very hardy cells and will grow on almost any 
surface. This is a poor cell choice to determine whether or 
not the decellularised tissues are cytocompatible. Without 
conducting additional experiments, at a minimum, a 
discussion of this point should be included.
Authors: International standards for medical devices (ISO 
10993) have been published by ISO in 1992 declaring 
that new medical devices must go through in vitro and 
in vivo biocompatibility tests (cytotoxicity, sensitisation, 
intradermal irritation, acute systemic toxicity, etc.) 
before entering into human clinical trials. Among the 
biocompatibility tests, the cytotoxicity is chosen as the 
leading test thanks to its ease, rapidity and high sensitivity. 
It is based on the analysis of cell growth, reproduction 
and morphological effects of the medical devices (Li 
et al., 2015). Commonly, in vitro basal cytotoxicity 
and cytocompatibility can be performed in different 
primary cells, as well as in a variety of permanent cell 
lines. However, established rodent cell lines, like mouse 
fibroblast NIH-3T3, are recommended because they assure 
in vitro reproducibility, in vivo prediction and a corroborate 
background of historical data. Moreover, NIH-3T3 cells, 
having a population doubling time ≤ 30 h, are capable 
of active division, during which chemicals exercise their 
toxicity. Therefore, the main advantages in using these 
cells are a short-term detection of cytocompatibility, high 
reproducibility, and easy availability as a commercial 
product. Differently, primary cells from humans are a 
highly variable source and greatly differentiated as well 
as undifferentiated cells may not give the best prediction 
of acute toxicity (Ekwall et al., 1998). Finally, in our case, 
the use of fibroblasts can resemble the fibroblast-like cells 
residing within the tendon structure. Indeed, NIH-3T3 cells 
secrete typical tendon ECM molecules, such as collagen 
type I, III and proteoglycans, and more interestingly they 
proliferate faster than tendon fibroblasts (Cooper et al., 
2014; Ning et al., 2012). Furthermore, several studies 
in the field of tendon decellularisation employed dermal 
fibroblasts to repopulate decellularised matrices. In 
particular, some of them used rabbit fibroblasts (Tischer 
et al., 2007; Tischer et al., 2010; Angelidis et al., 2010) 
or human fibroblasts (Woon et al., 2011; Raghavan et al., 
2012; Pridgen et al., 2011; Cartmell and Dunn 2004) that 
are not well-characterised cells as the NIH-3T3. However, 
because of the variability of the in vivo environment and of 
the implant-host interactions, a homogeneous analysis to 
test both the cytocompatibility and the cytotoxicity has not 
been established so far. Our cytocompatibility test needed 
to be a proof of concept of cell adhesion and viability 
onto the decellularised matrix. Thus, following this study, 
further experiments will be performed to evaluate the 
capability of more delicate cells (MSCs or tenocytes) in 
growing onto these decellularised tissues.
Walter Brehm: Why does the tendon appear so damaged?
Authors: The authors hypothesised that the damaged 
tendon structure of the decellularised matrix (DM) in Fig. 
7c,d could be related to the different plane of histologic 
sectioning. Indeed, it must be taken into account that the 
histologic sections reported in Fig. 7c,d were cut along 
the sagittal plane with respect to the tendon anatomy, in 
order to identify the presence of cells and their matrix onto 
the tendon surface. Differently, the histologic sections 
presented in Fig. 1 and 2 were cut along the coronal plane 
to be correctly compared to other similar studies. Thus, 
it is misleading to compare the homogeneous histologic 
texture reported in Fig. 1 and 2 to the damaged texture 
in Fig. 7 c,d. Moreover, the authors also hypothesised 
that the immersion of the small pieces of DM (5 mm × 
5 mm × 3 mm) in the culture medium for 7 d could have 
damaged the DM structure. In fact, the DM proteoglycans 
were affected not only by the decellularisation process, but 
also by the isotonic culture medium (Hunziker and Graber 
1986), determining an increased opening of the collagen 
fibres. Overall, the combination of proteoglycan decrease, 
the small dimensions of the samples and several days in 
contact with the culture medium at 37 °C can severely 
affect the cohesiveness of the tendon structure. For this 
reason, the fibres appeared more distant from each other.
Walter Brehm: Why is there a layer of unstructured 
connective tissue on the tendon in Fig. 7c but not in Fig. 7d? 
According to my experience, this layer was not synthesised 
by the cells but is derived from loose tendon fibres.
Authors: The layer of unstructured connective tissue 
onto the tendon matrix in Fig. 7c is determined by the 
fibroblast seeded on the surface of the decellularised 
matrix (DM), thus consisting in the reseeded matrix 
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(RM). Differently, in Fig. 7d, this layer was not present 
because this is the DM that was not reseeded with any 
cells. In Fig. 7c, the connective tissue layer appeared to 
be synthesised by fibroblasts in close contact with the 
tendon matrix. However, the newly formed connective 
tissue was completely disorganised. Indeed, in the absence 
of mechanical stimuli, as commonly happens in native 
tendons during loading, the loaded fibroblasts were largely 
oriented randomly in space, round-shaped and not aligned 
along the collagen fibre direction. This phenomenon is 
probably related to the absence of any mechanical stimuli 
or dynamic culture, in fact, our reseeding and culture 
of the decellularised matrix was performed under static 
conditions. As demonstrated in several similar studies and 
widely investigated in our previously published review 
(Lovati et al., 2016), the static culture had a significant 
influence in impeding both the cell penetration within the 
tendon fibres and the cell orientation along the collagen 
fibres.
Walter Brehm: Why do no cells migrate into the tissue, 
and why do all cells have a round morphology? Normally, 
they should be oriented between the tendon fibres.
Authors: In the recent literature (Lovati et al., 2016), 
similar results in terms of absence of cell penetration 
and presence of rounded cells were described by several 
studies, in which the decellularised tendon matrices were 
seeded and cultured under static conditions (Cartmell and 
Dunn 2004; Ning et al., 2012; Woon et al., 2011; Raghavan 
et al., 2012; Pridgen et al., 2011; Burk et al., 2014; Durgam 
et al., 2012). Different results, in terms of cell penetration 
within the decellularised matrix, were obtained by the 
authors that performed dynamic culture, a direct cell 
injection within the matrix fibres (Tischer et al., 2007), 
or matrix sonication. Other authors, despite performing 
a cell injection within the matrix fibres, described a cell 
distribution merely on the matrix surface (see in Lovati 
et al., 2016). Only Youngstrom et al. and Youngstrom 
et al. (2013 & 2015), despite better results obtained in 
dynamic conditions compared to static, declared a good 
cell infiltration in the static condition too. In particular, 
Youngstrom and colleagues performed the decellularisation 
by using a more aggressive detergent, such as the SDS. 
In the future, the authors of the current study are going to 
improve the decellularised matrix cell reseeding and culture 
under dynamic conditions by using a specifically custom-
made bioreactor in order to overcome these limitations 
in terms of cell colonisation of the tendon matrix core 
and correct deposition of newly formed connective tissue 
following the physiological orientation of the tendon fibres.
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